NIH Announces Phase III Clinical Trial of Creatine for Park
The NIH National Institute of Neurological Disorders and Stroke (NINDS) today is launching a large-scale clinical trial to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease (PD). &nbsp;»&nbsp;<a href='http://www.nih.gov/news/pr/mar2007/ninds-22.htm'>original news</a>

Read more...